NDC 50090-0874

EPZICOM

Abacavir Sulfate And Lamivudine

EPZICOM is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Abacavir Sulfate; Lamivudine.

Product ID50090-0874_a0b0db6c-48a5-43ce-af4f-012465362c40
NDC50090-0874
Product TypeHuman Prescription Drug
Proprietary NameEPZICOM
Generic NameAbacavir Sulfate And Lamivudine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2010-10-12
Marketing CategoryNDA / NDA
Application NumberNDA021652
Labeler NameA-S Medication Solutions
Substance NameABACAVIR SULFATE; LAMIVUDINE
Active Ingredient Strength600 mg/1; mg/1
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 50090-0874-0

30 TABLET, FILM COATED in 1 BOTTLE (50090-0874-0)
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-0874-0 [50090087400]

EPZICOM TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021652
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-11-28
Marketing End Date2019-06-30

Drug Details

Active Ingredients

IngredientStrength
ABACAVIR SULFATE600 mg/1

OpenFDA Data

SPL SET ID:7858fa09-2f2a-4645-b3a4-4bf9adddac75
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 602393
  • 602395
  • Pharmacological Class

    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    NDC Crossover Matching brand name "EPZICOM" or generic name "Abacavir Sulfate And Lamivudine"

    NDCBrand NameGeneric Name
    49349-701EpzicomAbacavir Sulfate and Lamivudine
    49702-206EPZICOMabacavir sulfate and lamivudine
    50090-0874EPZICOMabacavir sulfate and lamivudine
    53808-0767EPZICOMabacavir sulfate and lamivudine
    70518-0691EPZICOMabacavir sulfate and lamivudine
    66993-482Abacavir and Lamivudineabacavir sulfate and lamivudine

    Trademark Results [EPZICOM]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EPZICOM
    EPZICOM
    78372750 3017368 Live/Registered
    VIIV HEALTHCARE COMPANY
    2004-02-23

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.